0000920465-17-000083.txt : 20171213 0000920465-17-000083.hdr.sgml : 20171213 20171213210723 ACCESSION NUMBER: 0000920465-17-000083 CONFORMED SUBMISSION TYPE: 4 PUBLIC DOCUMENT COUNT: 1 CONFORMED PERIOD OF REPORT: 20171211 FILED AS OF DATE: 20171213 DATE AS OF CHANGE: 20171213 REPORTING-OWNER: OWNER DATA: COMPANY CONFORMED NAME: CARVER JENNIFER CENTRAL INDEX KEY: 0001663163 FILING VALUES: FORM TYPE: 4 SEC ACT: 1934 Act SEC FILE NUMBER: 001-36282 FILM NUMBER: 171255052 MAIL ADDRESS: STREET 1: 725 NEWPORT STREET CITY: DENVER STATE: CO ZIP: 80220 ISSUER: COMPANY DATA: COMPANY CONFORMED NAME: LA JOLLA PHARMACEUTICAL CO CENTRAL INDEX KEY: 0000920465 STANDARD INDUSTRIAL CLASSIFICATION: BIOLOGICAL PRODUCTS (NO DIAGNOSTIC SUBSTANCES) [2836] IRS NUMBER: 330361285 STATE OF INCORPORATION: CA FISCAL YEAR END: 1231 BUSINESS ADDRESS: STREET 1: 10182 TELESIS COURT, 6TH FLOOR CITY: SAN DIEGO STATE: CA ZIP: 92121 BUSINESS PHONE: 858-207-4264 MAIL ADDRESS: STREET 1: 10182 TELESIS COURT, 6TH FLOOR CITY: SAN DIEGO STATE: CA ZIP: 92121 4 1 wf-form4_151321722953500.xml FORM 4 X0306 4 2017-12-11 0 0000920465 LA JOLLA PHARMACEUTICAL CO LJPC 0001663163 CARVER JENNIFER C/O LA JOLLA PHARMACEUTICAL COMPANY, 4550 TOWNE CENTRE COURT SAN DIEGO CA 92121 0 1 0 0 Chief Operating Officer Stock Option (Right to Buy) 28.1 2017-12-11 4 A 0 49000 0 A 2027-12-11 Common Stock 49000.0 49000 D The stock option vests and becomes exercisable with respect to 25% of the underlying shares on the one-year anniversary of grant date and then vests and becomes exercisable ratably on a monthly basis over the next three years. /s/ Ryan Murr, as attorney-in-fact for Jennifer A. Carver 2017-12-13